Pricing Log in Create free account

Seer, Inc. (SEER) vs Tonix Pharmaceuticals Holding Corp. (TNXP)

Seer, Inc. and Tonix Pharmaceuticals Holding Corp. are both Biotechnology companies. Seer, Inc. and Tonix Pharmaceuticals Holding Corp. are of similar size ($113.0M and $110.1M). Tonix Pharmaceuticals Holding Corp. grew revenue faster over the last twelve months: 196.0% against −12.7%. Seer, Inc. has the higher net margin (−478.1% vs −548.6%) and the higher return on invested capital (−60.8% vs −224.5%). Across the 17 metrics below, Seer, Inc. leads on 10 and Tonix Pharmaceuticals Holding Corp. on 7.

Valuation

Metric SEER TNXP Biotechnology median
P/E n/m n/m 8.50
P/S 7.88 3.45 9.71
P/B 0.50 0.45 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.64 0.42 0.64
EV/Sales (2.87) (2.35) 9.21
Earnings yield (60.10%) (219.31%) (33.15%)
Free cash flow yield (39.27%) (157.36%) (25.50%)

Profitability

Metric SEER TNXP Biotechnology median
Gross margin 47.70% 83.83% 65.16%
Operating margin (498.19%) (568.43%) 0.00%
Net margin (478.05%) (548.64%) 0.00%
Free cash flow margin (309.34%) (543.29%) 0.00%
Return on equity (26.45%) (81.82%) (56.36%)
Return on assets (23.47%) (72.34%) (48.04%)
Return on invested capital (60.78%) (224.52%) 0.00%

Growth

Metric SEER TNXP Biotechnology median
Revenue growth (TTM) (12.71%) 196.02% 6.02%
EPS growth (last fiscal year) 7.91% 91.75% 30.26%
Revenue growth, 5-year CAGR 90.78% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SEER TNXP Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 14.74 6.61 4.72
Net debt to EBITDA 2.63 1.68 0.96

Dividend

Metric SEER TNXP Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric SEER TNXP Biotechnology median
Market cap 112.96m 110.11m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack